0001209191-24-001057.txt : 20240105
0001209191-24-001057.hdr.sgml : 20240105
20240105174345
ACCESSION NUMBER: 0001209191-24-001057
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240104
FILED AS OF DATE: 20240105
DATE AS OF CHANGE: 20240105
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Sprecher Jeffrey C
CENTRAL INDEX KEY: 0001343882
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36198
FILM NUMBER: 24517684
MAIL ADDRESS:
STREET 1: 2100 RIVEREDGE PARKWAY
STREET 2: SUITE 500
CITY: ATLANTA
STATE: GA
ZIP: 30308
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Intercontinental Exchange, Inc.
CENTRAL INDEX KEY: 0001571949
STANDARD INDUSTRIAL CLASSIFICATION: SECURITY & COMMODITY BROKERS, DEALERS, EXCHANGES & SERVICES [6200]
ORGANIZATION NAME: 02 Finance
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 5660 NEW NORTHSIDE DRIVE,
STREET 2: THIRD FLOOR
CITY: ATLANTA
STATE: GA
ZIP: 30328
BUSINESS PHONE: 770-857-4700
MAIL ADDRESS:
STREET 1: 5660 NEW NORTHSIDE DRIVE,
STREET 2: THIRD FLOOR
CITY: ATLANTA
STATE: GA
ZIP: 30328
FORMER COMPANY:
FORMER CONFORMED NAME: IntercontinentalExchange Group, Inc.
DATE OF NAME CHANGE: 20130313
FORMER COMPANY:
FORMER CONFORMED NAME: Intercontinental Exchange Group, Inc.
DATE OF NAME CHANGE: 20130312
4
1
doc4.xml
FORM 4 SUBMISSION
X0508
4
2024-01-04
0
0001571949
Intercontinental Exchange, Inc.
ICE
0001343882
Sprecher Jeffrey C
5660 NEW NORTHSIDE DRIVE
ATLANTA
GA
30328
1
1
0
0
Chief Executive Officer
1
Common Stock
2024-01-04
4
M
0
58388
50.01
A
1210763
D
Common Stock
2024-01-04
4
S
0
8401
125.0272
D
1202362
D
Common Stock
2024-01-04
4
S
0
46787
126.0228
D
1155575
D
Common Stock
2024-01-04
4
S
0
3200
126.4403
D
1152375
D
Common Stock
2024-01-04
4
S
0
15269
125.018
D
2866436
I
CPEX
Common Stock
2024-01-04
4
S
0
82150
125.9893
D
2784286
I
CPEX
Common Stock
2024-01-04
4
S
0
12581
126.4051
D
2771705
I
CPEX
Common Stock
81570
I
By spouse
Employee Stock Option (right to buy) Holding
50.01
2024-01-04
4
M
0
58388
0.00
D
2026-01-14
Common Stock
58388
116777
D
This transaction was effected pursuant to a Rule 10b5-1 trading plan which was approved and became effective as of August 7, 2023.
Amount of securities beneficially owned includes 110 shares acquired under the Intercontinental Exchange, Inc. Employee Stock Purchase Plan on December 29, 2023.
The price range for the aggregate amount sold by the direct holder is $124.41 - $125.39. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price.
The price range for the aggregate amount sold by the direct holder is $125.41 - $126.40. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price.
The price range for the aggregate amount sold by the direct holder is $126.41 - $126.50. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price.
The common stock number referred in Table I is an aggregate number and represents 1,110,990 shares of common stock and 41,385 unvested performance based restricted stock units, for which the performance period has been satisfied. These performance based restricted stock units vest over a three year period, in which 33.33% of the units vest each year. The satisfaction of the 2023 PSUs tied to earnings before interest, taxes, depreciation, and amortization, ("EBITDA") and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2024 and will be reported at the time of vesting. The satisfaction of the 2021, 2022 and 2023 total shareholder return performance based restricted stock units and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2024, February 2025 and February 2026, respectively, and will be reported at the time of vesting.
The satisfaction of the performance based restricted stock units granted as Deal Incentive Awards and the corresponding number of shares to be issued pursuant to these awards, will not be determined until December 2026, December 2027 and December 2028 and will be subject to additional time-based vesting conditions and, if applicable, a subsequent one-year holding period.
The price range for the aggregate amount sold by the direct holder is $124.34 - $125.33. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price.
The price range for the aggregate amount sold by the direct holder is $125.34 - $126.33. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price.
The price range for the aggregate amount sold by the direct holder is $126.34 - $126.50. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price.
As previously reported, the reporting person also indirectly owns 2,771,705 shares that are beneficially owned directly by CPEX. The reporting person beneficially owns 100% of the equity interest in CPEX. Additionally, as previously reported, the reporting person indirectly owns shares that are beneficially owned directly by the reporting person's spouse for which the reporting person disclaims beneficial ownership.
As previously reported, the reporting person also indirectly owns 81,570 shares that are beneficially owned directly by the reporting person's spouse for which the reporting person disclaims beneficial ownership.
These options are fully vested.
/s/ Octavia N. Spencer, Attorney-in-fact
2024-01-08